Stephen Mandel
Lone Pine Capital
Stephen Mandel Eli Lilly and Company stake
total: 304
Lone Pine Capital LLY trades
- Total transactions:
- 3
- New positions:
- 1
- Sold out:
- 1
- Reduced:
- 1
- Held since:
- 2024 Q4
- Held for:
- 2 quarters
- Latest activity:
- 2025 Q2
According to 2026 Q2 report, Stephen Mandel doesn't hold any Eli Lilly and Company (LLY) shares. To date, the estimated cost basis is nearly $772 for "buy" trades and estimated average "sell" price is $825.91. Lone Pine Capital first purchased LLY in 2024 Q4, initially acquiring 782,860 shares. Since the initial investment in Eli Lilly and Company (LLY), Lone Pine Capital has made 2 more transactions.
When did Stephen Mandel sell Eli Lilly and Company (LLY)?
Stephen Mandel sold off the entire Eli Lilly and Company (LLY) position in 2025 Q2.
When did Stephen Mandel buy Eli Lilly and Company (LLY)?
Stephen Mandel first invested in Eli Lilly and Company (LLY) in 2024 Q4 at the reported quarter-end price of $772.00 per share.
What's the cost basis of Lone Pine Capital's LLY stake?
The estimated cost basis for Eli Lilly and Company (LLY) stake is around $772.00 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $772.00
- Weighted AVG sell price:
- $825.91
Stephen Mandel's historical trades in Eli Lilly and Company
3 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q2
|
0.00%
|
0
|
$825.91
|
|
-100% (-551,827)
|
-3.99%
|
|
2025 Q1
|
3.99%
|
551,827
|
$825.91
|
$455,759,438
|
-29.51% (-231,033)
|
-1.42%
|
|
2024 Q4
|
4.49%
|
782,860
|
$772.00
|
$604,367,920
|
new
|
+4.49%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.